Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificate, as details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.
The above information is a part of company’s filings submitted to BSE.
